Peter Brent Sampson

This inventor holds 33 USPTO granted patents and 5 published patent applications, plus 26 CIPO patents and 12 EPO patents. Top assignees: University Health Network, Affinium Pharmaceuticals, Inc., Debiopharm International, S.a.. Active years: 2010-2024.

USPTO Granted Patents = 33 (Patent Applications = 5)

% Patents Active = 93.9

CIPO Patents = 26

EPO Patents = 12 (Patent Applications = 11)

Average Co-Inventor Count = 5.7

ph-index = 9

Forward Citations = 188(Granted Patents)

Location History:

Toronto, CA (2010)
Oakville, CA (2012 - 2024)

Company Filing History:

28 out of 311

University Health Network

patents

3 out of 33

Affinium Pharmaceuticals, Inc.

patents

1 out of 22

Debiopharm International, S.a.

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

TTK Inhibitor

PLK-4 Inhibitor

HPK1 Inhibitors

Kinase Inhibitors

Pyrazolopyrimidine Compounds

Chiral Synthesis

Indazole Compounds

Acrylamide Derivatives

Cyclic Inhibitors

Carnitine Palmitoyltransferase

Therapeutic Agents

Heterocyclic Compounds

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11878980 - Solid forms of TTK inhibitor (2024-01-23),

2. 11667627 - Salt and crystal forms of PLK-4 inhibitor (2023-06-06),

3. 11104681 - Solid forms of TTK inhibitor (2021-08-31),

4. 11059832 - HPK1 inhibitors and methods of using same (2021-07-13),

5. 10919886 - Salt and crystal forms of PLK-4 inhibitor (2021-02-16),

6. 10584130 - Solid forms of TTK inhibitor (2020-03-10),

7. 10570143 - Pyrazolopyrimidine compounds (2020-02-25),

8. 10501474 - HPK1 inhibitors and methods of using same (2019-12-10),

9. RE47731 - Kinase inhibitors and method of treating cancer with same (2019-11-18),

10. 10472353 - Salt and crystal forms of PLK-4 inhibitor (2019-11-12),

11. 10392374 - Salt and crystal forms of PLK-4 inhibitor (2019-08-27),

12. 10358436 - Kinase inhibitors and method of treating cancer (2019-07-23),

13. 10106545 - Pyrazolopyrimidine compounds (2018-10-23),

14. 10077255 - Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2′-ones (2018-09-18),

15. 9907800 - Kinase inhibitors and method of treating cancer (2018-03-06),

Title: The Innovative Journey of Peter Brent Sampson

Introduction: Peter Brent Sampson, a visionary inventor hailing from Oakville, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Peter Brent Sampson's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Peter Brent Sampson has established himself as a pioneer in the tech industry. His innovative spirit has led to the development of numerous products that have enhanced the way we live and work.

Collaborations: Throughout his career, Peter Brent Sampson has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Peter Brent Sampson's relentless pursuit of innovation and his passion for creating technology that makes a positive impact on society continue to inspire the next generation of inventors. His legacy as a forward-thinker and problem-solver is sure to endure for years to come.